# BOSULIF
> **NDA203341** · New Drug Application · Sponsor: PF PRISM CV · Approved 2012-09-04
## Drug
- **FDA Application Number:** NDA203341
- **Application type:** New Drug Application
- **Brand name:** BOSULIF
- **Generic name:** BOSUTINIB
- **Active ingredients:** BOSUTINIB MONOHYDRATE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** PF PRISM CV
- **Manufacturer:** Pfizer Laboratories Div Pfizer Inc
- **First approval:** 2012-09-04
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203341)
---
*MORVS · CC0 1.0*